Stem Cell Therapy Global Market Report 2024 - By Demand, Growth, Share, Trends, Outlook By 2033

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Stem Cell Therapy Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $13.12 billion In 2028 At A CAGR Of 13.4% :
The stem cell therapy market size has grown exponentially in recent years. It will grow from $6.43 billion in 2023 to $7.94 billion in 2024 at a compound annual growth rate (CAGR) of 23.5%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, a rise in funding from governments and private organizations, rapid growth in emerging markets, an increase in investments in cell and gene therapies, surge in healthcare expenditure, and an increase in pharmaceutical r&d expenditure.

The stem cell therapy market size is expected to see rapid growth in the next few years. It will grow to $13.12 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing government support, rapid increase in the aging population, rising research and development spending, and increasing healthcare expenditure. Major trends in the forecast period include focus on closely monitoring advances in mesenchymal stem cells therapy with a view to capitalizing on innovations in the field, market players should collaborate with, and acquire other companies to further advance product innovation and to drive revenues, companies should consider investing in developing of ipsc-derived nk cells to treat patients, companies operating in the stem cell therapy market should concentrate on developing stem cell therapy, especially for cancer to gain a competitive advantage over somatic cell competitors, and companies operating in the stem cell therapy market should make use of artificial intelligence to improve product quality, safety and manufacturing productivity.

Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

Stem Cell Therapy Market Major Segments
The stem cell therapy market covered in this report is segmented -
1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy
2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells
3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others
4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Key Driver - Increasing Prevalence Of Chronic Diseases To Drive Market Growth
The rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases among people, thus driving the need for stem cell therapy. According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. The rising prevalence of chronic diseases is expected to drive the stem cell therapy market growth.

Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=3399&type=smp

Prominent Trend - Collaborative Partnership In Research And Development Transforming The Stem Cell Therapy Market
The companies in the stem cell therapy market are increasingly investing in strategic partnerships. A strategic partnership is a mutually beneficial agreement between two companies that do not compete directly with each other. For instance, in May 2022, SQZ Biotechnologies, a US-based biotechnology company partnered with STEMCELL Technologies Inc., a Canada-based biotechnology company to develop and commercialize a research-use-only (RUO) microfluidic intracellular delivery system, based on SQZ's Cell Squeeze technology, providing the life sciences community with enhanced cell engineering capabilities for preclinical research. Both companies will present significant findings about the potential of the RUO system in efficiently delivering cargoes to primary immune cell types and demonstrating advancements in cell engineering with mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Stem Cell Therapy Market Players
Major companies operating in the stem cell therapy market report are Smith & Nephew Plc, Fujifilm Holding Corporation, Thermo Fisher Scientific Inc, Takara Bio Inc, MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Reelabs Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Adimmune, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals , Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mol Med, Selvita, Mabion, Pure Biologics, Oncoarendi Therapeutics, Captor Therapeutics, Celon Pharma, Nanovelos, Dickinson And Company, Sigma Aldrich (A Subsidiary Of Merck Kgaa), Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Celgene Corporation, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Adcock Ingram, Bayer East Africa Ltd, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi

View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the stem cell therapy market in 2023. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Stem Cell Therapy Market Report Structure
3. Stem Cell Therapy Market Trends And Strategies
4. Stem Cell Therapy Market - Macro Economic Scenario
5. Stem Cell Therapy Market Size And Growth
…..
27. Stem Cell Therapy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.